These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 1282614

  • 1. Stunned and hibernating myocardium: possibility of intervention.
    Ferrari R, La Canna G, Giubbini R, Visioli O.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S5-13. PubMed ID: 1282614
    [Abstract] [Full Text] [Related]

  • 2. Particular outcomes of myocardial ischaemia: stunning and hibernation.
    Ferrari R, Visioli O.
    Pharmacol Res; 1995; 31(3-4):235-41. PubMed ID: 7630864
    [Abstract] [Full Text] [Related]

  • 3. Characterization of "hibernating" and "stunned" myocardium with focus on the use of calcium antagonists in "stunned" myocardium.
    Ehring T, Schulz R, Heusch G.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S25-33. PubMed ID: 1282610
    [Abstract] [Full Text] [Related]

  • 4. [Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].
    Heusch G.
    Z Kardiol; 1992 Nov; 81(11):596-609. PubMed ID: 1471397
    [Abstract] [Full Text] [Related]

  • 5. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R.
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [Abstract] [Full Text] [Related]

  • 6. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R.
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [Abstract] [Full Text] [Related]

  • 7. Hibernating myocardium: a review.
    Heusch G, Schulz R.
    J Mol Cell Cardiol; 1996 Dec; 28(12):2359-72. PubMed ID: 9004153
    [Abstract] [Full Text] [Related]

  • 8. [Pathophysiology of the "hibernating" myocardium].
    Schulz R, Heusch G.
    Z Kardiol; 1995 Dec; 84 Suppl 4():91-100. PubMed ID: 8585279
    [Abstract] [Full Text] [Related]

  • 9. [Chronic myocardial ischemia--hibernating myocardium: characteristics and limits].
    Heusch G, Schulz R.
    Z Kardiol; 1993 Dec; 82 Suppl 5():133-41. PubMed ID: 8154154
    [Abstract] [Full Text] [Related]

  • 10. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation.
    Ferrari R, Ceconi C, Curello S, Benigno M, La Canna G, Visioli O.
    J Cardiovasc Pharmacol; 1996 Dec; 28 Suppl 1():S18-26. PubMed ID: 8891867
    [Abstract] [Full Text] [Related]

  • 11. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL, Kloner RA.
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [Abstract] [Full Text] [Related]

  • 12. Stunning: damaging or protective to the myocardium?
    Ferrari R, Visioli O.
    Cardiovasc Drugs Ther; 1991 Oct; 5(5):939-45. PubMed ID: 1756141
    [Abstract] [Full Text] [Related]

  • 13. Characterization of hibernating and stunned myocardium.
    Schulz R, Heusch G.
    Herz; 1994 Aug; 19(4):189-203. PubMed ID: 7959533
    [Abstract] [Full Text] [Related]

  • 14. Regional blood flow and contractile function: are they matched in normal, ischemic and reperfused myocardium?
    Heusch G, Schipke JD.
    Basic Res Cardiol; 1993 Aug; 88 Suppl 2():103-19. PubMed ID: 8147827
    [Abstract] [Full Text] [Related]

  • 15. [Molecular mechanisms for protecting the heart].
    Andres J.
    Folia Med Cracov; 1994 Aug; 35(1-4):22-30. PubMed ID: 8586324
    [Abstract] [Full Text] [Related]

  • 16. Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury.
    Milei J, Fraga CG, Grana DR, Ferreira R, Ambrosio G.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2329-36. PubMed ID: 15193702
    [Abstract] [Full Text] [Related]

  • 17. [Reversible dysfunction of myocardial contraction].
    Mates M, Veselka J.
    Vnitr Lek; 1998 Oct 16; 44(10):598-605. PubMed ID: 10422494
    [Abstract] [Full Text] [Related]

  • 18. [Hibernating myocardium: no involvement of endogenous adenosine].
    Schulz R, Heusch G.
    Z Kardiol; 1996 Oct 16; 85 Suppl 6():177-84. PubMed ID: 9064963
    [Abstract] [Full Text] [Related]

  • 19. [Postischemic ("stunned") and chronic ischemic ("hibernating") cardiac muscle].
    Takác M, Koval S, Takác V.
    Vnitr Lek; 1995 Apr 16; 41(4):252-7. PubMed ID: 7762191
    [Abstract] [Full Text] [Related]

  • 20. Reversible myocardial dysfunction: basics and evaluation.
    Gowda RM, Khan IA, Vasavada BC, Sacchi TJ.
    Int J Cardiol; 2004 Dec 16; 97(3):349-53. PubMed ID: 15561318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.